| Artificial intelligence in cancer diagnosis and prognosis: Opportunities and challenges S Huang, J Yang, S Fong, Q Zhao Cancer letters 471, 61-71, 2020 | 610 | 2020 |
| Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 G Zhou, Q Zhao International Journal of Biological Sciences 16 (10), 1718, 2020 | 223 | 2020 |
| Phototheranostic metal-phenolic networks with antiexosomal PD-L1 enhanced ferroptosis for synergistic immunotherapy L Xie, J Li, G Wang, W Sang, M Xu, W Li, J Yan, B Li, Z Zhang, Q Zhao, ... Journal of the American Chemical Society 144 (2), 787-797, 2022 | 214 | 2022 |
| Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countries R Xie, XD Zhang, Q Zhao, B Peng, J Zheng Emerging microbes & infections 7 (1), 1-10, 2018 | 212 | 2018 |
| B7-H3, a checkpoint molecule, as a target for cancer immunotherapy S Yang, W Wei, Q Zhao International journal of biological sciences 16 (11), 1767, 2020 | 210 | 2020 |
| Photosensitization priming of tumor microenvironments improves delivery of nanotherapeutics via neutrophil infiltration D Chu, X Dong, Q Zhao, J Gu, Z Wang Advanced Materials 29 (27), 1701021, 2017 | 175 | 2017 |
| Artificial intelligence in the diagnosis of COVID-19: challenges and perspectives S Huang, J Yang, S Fong, Q Zhao International journal of biological sciences 17 (6), 1581, 2021 | 156 | 2021 |
| Artificial intelligence in lung cancer diagnosis and prognosis: Current application and future perspective S Huang, J Yang, N Shen, Q Xu, Q Zhao Seminars in Cancer Biology 89, 30-37, 2023 | 151 | 2023 |
| Spectrin: structure, function and disease R Zhang, CY Zhang, Q Zhao, DH Li Science China Life Sciences 56, 1076-1085, 2013 | 133 | 2013 |
| Nanoparticle targeting of neutrophils for improved cancer immunotherapy D Chu, Q Zhao, J Yu, F Zhang, H Zhang, Z Wang Advanced healthcare materials 5 (9), 1088-1093, 2016 | 130 | 2016 |
| Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies Z Zhu, HR Qin, W Chen, Q Zhao, X Shen, R Schutte, Y Wang, G Ofek, ... Journal of virology 85 (21), 11401-11408, 2011 | 127 | 2011 |
| Polyphenol‐based nanomedicine evokes immune activation for combination cancer treatment Z Zhang, W Sang, L Xie, W Li, B Li, J Li, H Tian, Z Yuan, Q Zhao, Y Dai Angewandte Chemie International Edition 60 (4), 1967-1975, 2021 | 121 | 2021 |
| Humanized affinity-matured monoclonal antibody 8H9 has potent antitumor activity and binds to FG loop of tumor antigen B7-H3 M Ahmed, M Cheng, Q Zhao, Y Goldgur, SM Cheal, HF Guo, SM Larson, ... Journal of Biological Chemistry 290 (50), 30018-30029, 2015 | 120 | 2015 |
| Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy L Xie, G Wang, W Sang, J Li, Z Zhang, W Li, J Yan, Q Zhao, Y Dai Biomaterials 269, 120638, 2021 | 103 | 2021 |
| Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential Q Zhao, M Ahmed, DV Tassev, A Hasan, TY Kuo, HF Guo, RJ O'Reilly, ... Leukemia 29 (11), 2238-2247, 2015 | 102 | 2015 |
| Building potent chimeric antigen receptor T cells with CRISPR genome editing J Liu, G Zhou, L Zhang, Q Zhao Frontiers in immunology 10, 456, 2019 | 95 | 2019 |
| Immunogenomic analyses of advanced serous ovarian cancer reveal immune score is a strong prognostic factor and an indicator of chemosensitivity D Hao, J Liu, M Chen, JJ Li, L Wang, X Li, Q Zhao, L Di Clinical Cancer Research 24 (15), 3560-3571, 2018 | 81 | 2018 |
| Remodeling of tumor microenvironment by tumor‐targeting nanozymes enhances immune activation of CAR T cells for combination therapy L Zhu, J Liu, G Zhou, TM Liu, Y Dai, G Nie, Q Zhao Small 17 (43), 2102624, 2021 | 78 | 2021 |
| Bispecific antibodies for autoimmune and inflammatory diseases: clinical progress to date Q Zhao BioDrugs 34 (2), 111-119, 2020 | 76 | 2020 |
| Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes J Liu, S Yang, B Cao, G Zhou, F Zhang, Y Wang, R Wang, L Zhu, Y Meng, ... Journal of hematology & oncology 14, 1-18, 2021 | 72 | 2021 |